“gene-therapy” Archives

in
Entry Author Date Location
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
UniQure to Yank Pioneering Gene Therapy From Market in Europe 04/20/17 Boston
Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies 04/11/17 Boston
Angionetics Nears Key Gene Therapy Trial for Coronary Heart Disease 04/04/17 San Diego
Next Stop on Father’s Duchenne Quest: Wall Street? Solid Raises $50M 03/30/17 Boston
Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain Cancer 03/10/17 San Diego
Nonprofit Seeds Exonics to Fund Push For CRISPR Duchenne Treatment 02/27/17 Boston
His Gene Therapy Near Approval, Spark CEO Wonders: What Price Vision? 02/16/17 New York
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
Investors Sour on Data Debut For Dimension’s Hemophilia Gene Therapy 01/31/17 Boston
Notes From The JPM ’17 Vortex: Trump, Rainstorms & The Price You Pay 01/13/17 National
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
Voyager’s Gene Therapy for Parkinson’s Shows Promise in Small Study 12/07/16 Boston
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Fresh Off ASH Data, Spark Teams With Selecta to Boost Gene Therapies 12/05/16 Boston
Struggling UniQure Cuts Gene Therapies, Jobs, in Big Restructuring 11/15/16 Boston
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
New Data Show Power, Limits of Bluebird’s Gene Therapy For Blood Diseases 11/03/16 Boston
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
With Upgraded Tech, Bluebird Updates Regulatory Path For Gene Therapy 10/13/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Allergan Dips Toes into Gene Therapy With $60M Retrosense Buy 09/06/16 Detroit Ann Arbor
Novartis Disbands T Cell Group But Promises To Press Ahead In CAR-T Race 08/31/16 National
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Shire Steps Back in Hemophilia Gene Therapy Race, Scraps Baxalta Drug 08/03/16 Boston
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy 07/28/16 National
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Page 1 of 7 next page »